HBV DNA Integration and Somatic Mutations in HCC Patients with HBV-HCV Dual Infection
Author Information
Author(s): Li Chiao-Ling, Hsu Chia-Lang, Lin You-Yu, Ho Ming-Chih, Hu Rey-Heng, Tzeng Sheng-Tai, Wang Ya-Chun, Tanaka Yasuhito
Primary Institution: National Taiwan University College of Medicine
Hypothesis
HBV DNA integration could indicate HCC originating from hepatocytes infected or primed with HBV in HBV/HCV-dual infected patients.
Conclusion
The study reveals that HCV superinfection may delay HBV-induced carcinogenesis and lead to tumor characteristics more akin to those of HCV-HCC.
Supporting Evidence
- 55% of HBCV-HCCs exhibited clonal HBV integration.
- HBCV-HCC patients had an intermediate age at HCC diagnosis between HBV-HCC and HCV-HCC patients.
- HCV superinfection may delay HBV-induced carcinogenesis.
Takeaway
This study shows that having both hepatitis B and C can change how liver cancer develops, making it take longer to show up.
Methodology
The study analyzed HBV DNA integration in 313 HCC cases using next generation sequencing and compared clinical characteristics among HBV-HCC, HCV-HCC, and HBCV-HCC patients.
Limitations
The sample size for some comparisons was limited, which may affect the statistical significance of the findings.
Participant Demographics
Patients included 164 HBV-HCC, 56 HCV-HCC, and 93 HBCV-HCC cases, with a median age of diagnosis varying among groups.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website